Tokyo Cooperative Oncology Group

Tokyo Cooperative Oncology Group (TCOG) is a leading Japanese non-profit organization and academic research group specializing in the design and execution of multicenter clinical trials for cancer. Founded in 1995, the group facilitates collaboration between academic institutions and hospitals to evaluate innovative therapeutic strategies and improve clinical outcomes for cancer patients. TCOG primarily focuses on gastrointestinal, thoracic, and breast malignancies, conducting trials that range from early-phase studies to large-scale Phase 3 evaluations. As an Academic Research Organization (ARO), it provides essential services including protocol development, data management, and statistical analysis. The organization's research has been instrumental in defining standard-of-care treatments in Japan, particularly in the use of chemotherapy and molecularly targeted agents. TCOG remains a vital component of the Japanese oncology landscape, bridging the gap between clinical research and daily medical practice.